Defining the conformational states that enable transglutaminase 2 to promote cancer cell survival versus cell death

Cody Aplin,Kara A. Zielinski,Suzette Pabit,Deborah Ogunribido,William P. Katt,Lois Pollack,Richard A. Cerione,Shawn K. Milano

DOI: https://doi.org/10.1101/2024.02.04.578794

2024-02-08

Abstract:Transglutaminase 2 (TG2) is a GTP-binding/protein-crosslinking enzyme that has been investigated as a therapeutic target for Celiac disease, neurological disorders, and aggressive cancers. TG2 has been suggested to adopt two conformational states that regulate its functions: a GTP-bound, closed conformation, and a calcium-bound, crosslinking-active open conformation. TG2 mutants that constitutively adopt an open conformation are cytotoxic to cancer cells. Thus, small molecules that maintain the open conformation of TG2 could offer a new therapeutic strategy. Here, we investigate TG2, using static and time-resolved small-angle X-ray scattering (SAXS) and single-particle cryoelectron microscopy (cryo-EM), to determine the conformational states responsible for conferring its biological effects. We also describe a newly developed TG2 inhibitor, LM11, that potently kills glioblastoma cells and use SAXS to investigate how LM11 affects the conformational states of TG2. Using SAXS and cryo-EM, we show that guanine nucleotide-bound TG2 adopts a monomeric closed conformation while calcium-bound TG2 assumes an open conformational state that can form higher order oligomers. SAXS analysis also suggests how a TG2 mutant that constitutively adopts the open state binds nucleotides through an alternative mechanism to wildtype TG2. Furthermore, we use time-resolved SAXS to show that LM11 increases the ability of calcium to drive TG2 to an open conformation, which is not reversible by guanine nucleotides and is cytotoxic to cancer cells. Taken together, our findings demonstrate that the conformational dynamics of TG2 are more complex than previously suggested and highlight how conformational stabilization of TG2 by LM11 maintains TG2 in a cytotoxic conformational state.

Biophysics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to determine the conformational states of transglutaminase 2 (TG2) in the transition between promoting cancer cell survival and inducing cell death. Specifically, the researchers hope to describe the conformational changes related to TG2 activation and inhibition by advanced structural methods, and define how small - molecule inhibitors maintain TG2 in a structural state capable of killing cancer cells. TG2 is a multifunctional protein, and its conformational changes have different effects on cells, which can promote cancer cell survival or lead to cell death. Through static and time - resolved small - angle X - ray scattering (SAXS) and single - particle cryo - electron microscopy (cryo - EM), the researchers aim to analyze these conformational changes and their biological effects in detail, especially to explore how the newly developed TG2 inhibitor LM11 affects the conformational state of TG2, thereby effectively killing glioblastoma cells.

The key points of the paper include:
1. **Conformational states of TG2**: TG2 mainly exists in two conformational states, one is the nucleotide - bound closed conformation, and the other is the calcium - ion - bound open conformation. These two conformational states determine the function of TG2.
2. **Role of small - molecule inhibitors**: The researchers have developed a new TG2 inhibitor LM11, which can effectively kill glioblastoma cells. Through SAXS analysis, the researchers found that LM11 can enhance the ability of calcium ions to drive TG2 into the open conformation, which cannot be reversed by nucleotides and is cytotoxic to cancer cells.
3. **Complexity of conformational dynamics**: Through SAXS and cryo - EM, the researchers have shown that the conformational dynamics of TG2 is more complex than previously thought, emphasizing the mechanism by which LM11 exerts its effect by stabilizing the cytotoxic conformational state of TG2.

In summary, this paper aims to gain an in - depth understanding of the conformational changes of TG2 and its role in cancer, and provide a theoretical basis for the development of new TG2 inhibitors.